DEXCOM, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
DEXCOM, INC. (DXCM) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $30.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-02-12
- DEXCOM, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-03-31 was $1.90M.
- DEXCOM, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-12-31 was $16.30M, a 1711.11% increase year-over-year.
- DEXCOM, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-09-30 was $100.00K, a 94.44% decline year-over-year.
- DEXCOM, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-06-30 was $500.00K, a 0.00% change year-over-year.
- DEXCOM, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $30.40M, a 245.45% increase from fiscal 2024.
- DEXCOM, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $8.80M, a 17.33% increase from fiscal 2023.
- DEXCOM, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $7.50M, a 51.92% decline from fiscal 2022.
- DEXCOM, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $15.60M, a 19.08% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $30.40M 10-K · filed 2026-02-12 | ||||
| 2024-12-31 | $8.80M 10-K · filed 2026-02-12 | ||||
| 2023-12-31 | $7.50M 10-K · filed 2026-02-12 | ||||
| 2023-03-31 | $1.90M 10-Q · filed 2023-04-27 | $18.20M derived: sum of 2 quarters · filed 2025-02-18 | $18.30M derived: sum of 3 quarters · filed 2025-02-18 | $18.80M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2022-12-31 | $16.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $16.40M derived: sum of 2 quarters · filed 2025-02-18 | $16.90M derived: sum of 3 quarters · filed 2025-02-18 | $15.60M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $600.00K derived: sum of 2 quarters · filed 2022-10-27 | -$700.00K 10-Q · filed 2022-10-27 | $200.00K derived: sum of 4 quarters · filed 2024-02-08 | |
| 2022-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | -$800.00K 10-Q · filed 2022-07-28 | $100.00K derived: sum of 3 quarters · filed 2024-02-08 | $1.90M derived: sum of 4 quarters · filed 2024-02-08 | |
| 2022-03-31 | -$1.30M 10-Q · filed 2023-04-27 | -$400.00K derived: sum of 2 quarters · filed 2024-02-08 | $1.40M derived: sum of 3 quarters · filed 2024-02-08 | $1.90M derived: sum of 4 quarters · filed 2024-02-08 | |
| 2021-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $2.70M derived: sum of 2 quarters · filed 2024-02-08 | $3.20M derived: sum of 3 quarters · filed 2024-02-08 | $13.10M 10-K · filed 2024-02-08 | |
| 2021-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $2.30M derived: sum of 2 quarters · filed 2022-10-27 | $12.20M 10-Q · filed 2022-10-27 | $10.90M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $10.40M 10-Q · filed 2022-07-28 | $9.10M derived: sum of 3 quarters · filed 2023-02-09 | $38.60M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-03-31 | $9.90M 10-Q · filed 2022-04-28 | $8.60M derived: sum of 2 quarters · filed 2023-02-09 | $38.10M derived: sum of 3 quarters · filed 2023-02-09 | $38.10M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2020-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $28.20M derived: sum of 2 quarters · filed 2023-02-09 | $28.20M derived: sum of 3 quarters · filed 2023-02-09 | $33.50M 10-K · filed 2023-02-09 | |
| 2020-09-30 | $29.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $29.50M derived: sum of 2 quarters · filed 2021-10-28 | $34.80M 10-Q · filed 2021-10-28 | $58.20M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $5.30M 10-Q · filed 2021-07-29 | $28.70M derived: sum of 3 quarters · filed 2022-02-14 | $30.10M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-03-31 | $5.30M 10-Q · filed 2021-04-29 | $28.70M derived: sum of 2 quarters · filed 2022-02-14 | $30.10M derived: sum of 3 quarters · filed 2022-02-14 | $41.00M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2019-12-31 | $23.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $24.80M derived: sum of 2 quarters · filed 2022-02-14 | $35.70M derived: sum of 3 quarters · filed 2022-02-14 | $80.60M 10-K · filed 2022-02-14 | |
| 2019-09-30 | $1.40M 10-Q · filed 2019-11-06 | $12.30M derived: sum of 2 quarters · filed 2019-11-06 | $57.20M 10-Q · filed 2020-10-27 | $41.70M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $10.90M 10-Q · filed 2019-07-31 | $40.30M 10-Q · filed 2019-07-31 | |||
| 2019-03-31 | $29.90M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |